Skip Navigation
Skip to contents

KDDW 2024


Speakers

Home    >    Program    >    Speakers

Member Societies

˻
  • * Bookmark: To add speakers to your Favorites, log in and click 'Star.' Your Favorites List can be found on My Page.

[The 8th Joint Session between KDDW-TDDW-JDDW] Pancreatobiliary : Nov. 15 (Fri), 09:00-11:15
Latest advances in endoscopic/EUS-guided diagnosis and treatment for pancreatobiliary tumor

  • Paradigm shift of endoscopic treatment in advanced malignant hilar obstruction Tae Hoon Lee
    Soonchunhyang University, Korea
    CV ã
  • Is it time to replace duodenal self-expandable metal stent by EUS-guided gastroenterostomy for malignant gastric outlet obstruction from pancreatic cancer? Kuei-Chuan Lee
    Taipei Veterans General Hospital, Taiwan
    CV ã
  • EUS-guided biliary drainage for malignant biliary obstruction Yousuke Nakai
    Tokyo Women's Medical University, Japan
    CV ã
  • General Discussion Jong Jin Hyun
    Korea University, Korea
    ã
  • Advancements and challenges in endoscopic ablation therapy for pancreatic tumor Jae Min Lee
    Korea University, Korea
    CV ã
  • The Impact of glucose-containing fluids on the outcomes of acute pancreatitis Hsing-Chien Wu
    National Taiwan University Hospital, Taiwan
    CV ã
  • Metal versus plastic stents for preoperative biliary drainage in patient receiving neo-adjuvant chemotherapy Takashi Tamura
    Wakayama Medical University, Japan
    CV ã

[The 8th Joint Session between KDDW-TDDW-JDDW] Upper GI : Nov. 15 (Fri), 09:00-11:15
From traditional wisdom to innovative practice in the management of non-variceal upper gastrointestinal bleeding

  • Novel therapeutics and future directions in the management of NVUGIB Sun Hyung Kang
    Chungnam National University, Korea
    CV ã
  • Innovative treatments for non-variceal bleeding: Taiwan's perspective Chu-Kuang Chou
    Chia-Yi Christian Hospital, Taiwan
    CV ã
  • Current status and future perspective in the management for non-variceal upper GI bleeding in Japan Waku Hatta
    Tohoku University, Japan
    CV ã
  • General Discussion Joon Sung Kim
    The Catholic University of Korea, Korea
    ã
  • A randomized control study evaluating the efficacy of a hemostatic powder (UI-EWD) in decreasing the rate of upper gastrointestinal re-bleeding in patients treated with endoscopic therapy for high-risk lesions Boram Cha
    Inha University, Korea
    CV ã
  • Precise and optimal drug powder delivery in gastrointestinal bleeding Hsueh-Chien Chiang
    National Cheng Kung University Hospital, Taiwan
    CV ã
  • Management of all upper GI bleeding using the Horibe GI bleeding score (HARBINGER) Masayasu Horibe
    Keio University, Japan
    CV ã

Combined Symposium 04 (KSG+UEG) : Nov. 15 (Fri), 10:20-11:50
From autoimmune pancreatitis to pancreatic cancer: a multidisciplinary challenge

  • Cancer risk in chronic and autoimmune pancreatitis Matthias Löhr
    Karolinska Institutet, Sweden
    CV ã
  • Pathological diagnosis of autoimmune pancreatitis Kee-Taek Jang
    Samsung Medical Center, Korea
    CV ã
  • A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer Sung-Hoon Moon
    Hallym University, Korea
    CV ã
  • T Lymphocytes: a promising immunotherapeutic target for autoimmune pancreatitis and pancreatic cancer? Lena Seifert
    University Hospital Dresden, Germany
    CV ã

Symposium 17 : Nov. 15 (Fri), 10:20-11:50
Update and latest advances in systemic treatment for HCC

  • Adverse events of atezolizumab and bevacizumab in HCC: risk factors and dose modification Sangyoun Hwang
    Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Korea
    CV ã
  • Imaging biomarkers for response evaluation of atezolizumab and bevacizumab in HCC Kyowon Gu
    Sungkyunkwan University, Korea
    CV ã
  • Adjuvant and combined roles of systemic treatment in HCC Yu Rim Lee
    Kyungpook National University, Korea
    CV ã
  • Blood- and tissue-based tools to guide optimal systemic treatment in HCC Stephen Lam Chan
    The Chinese University of Hong Kong, Hong Kong
    CV ã

Symposium 18 : Nov. 15 (Fri), 10:20-11:50
Deep insight of IBD: next-generation care and therapy

  • Better risk stratification in IBD - can we predict the prognosis? Eun Mi Song
    Ewha Womans University, Korea
    CV ã
  • Refractory IBD: dual targeted therapies or novel approaches? Hyuk Yoon
    Seoul National University, Korea
    CV ã
  • Microbiome-modulating therapies in IBD Hong Koh
    Yonsei University, Korea
    CV ã
  • Translating evolving treatment targets into clinical practice in the AI era Yasuharu Maeda
    Showa University Northern Yokohama Hospital, Japan
    CV ã

Combined Symposium 05 (KSNM+KSGE) : Nov. 15 (Fri), 10:20-11:50
All about microbiologic approach in IBS

  • Brain-gut-microbiota axis in IBS Seung Yong Shin
    Chung-Ang University, Korea
    CV ã
  • Role of live biotherapeutic products for IBS Yong Sung Kim
    Wonkwang University, Korea
    CV ã
  • Advancements in FMT therapy for IBS: Where do we stand? Jae Hyun Kim
    Kosin University, Korea
    CV ã
  • How to implement FMT in our clinics Jongbeom Shin
    Inha University, Korea
    CV ã

Combined Symposium 06 (KSGC+KPBA) : Nov. 15 (Fri), 10:20-11:50
Cutting-edge multimodality therapeutics in intrahepatic cholangiocarcinoma: advancing integrated treatment strategies

  • Optimizing surgical outcomes: strategies for patient selection and advanced surgical techniques Jihun Kim
    University of Ulsan, Korea
    ã
  • Definitive radiotherapy for loco-regional or recurrent IHCC: precision and progress Kyubo Kim
    Seoul National University, Korea
    CV ã
  • Microenvironments and new therapeutic targets Dong Uk Kim
    CHA University, Korea
    CV ã
  • Beyond Gem/Cis: evolution of immunotherapy and targeted therapy for advanced IHCC Jaihwan Kim
    Seoul National University, Korea
    CV ã

PG Course 02 : Nov. 15 (Fri), 10:20-11:50
Clinical guideline update

  • Management of subepithelial lesion Seung Joo Kang
    Seoul National University, Korea
    CV ã
  • Percutaneous endoscopic gastrostomy Chung Hyun Tae
    Ewha Womans University, Korea
    CV ã
  • Atrophic gastritis and intestinal metaplasia Su Youn Nam
    Kyungpook National University, Korea
    CV ã
  • Endoscopic resection of early gastrointestinal cancer Hyeong Ho Jo
    Daegu Catholic University, Korea
    CV ã

Symposium 19 : Nov. 15 (Fri), 13:20-14:50
Management of superficial esophageal cancer

  • Effect of an artificial intelligence-assisted system on endoscopic diagnosis Jun-Won Chung
    Gachon University, Korea
    CV ã
  • Treatment strategy of early stage esophageal cancer Donghoon Kang
    The Catholic University of Korea, Korea
    CV ã
  • Applications of Minimally Invasive Surgery in Superficial Esophageal Cancer Jun Hee Lee
    Korea University, Korea
    CV ã
  • Optimizing Survival: Concurrent Chemoradiotherapy after Non-Curative Endoscopic treatment Dongryul Oh
    Sungkyunkwan University, Korea
    CV ã

Combined Symposium 07 (KPBA+KSGE) : Nov. 15 (Fri), 13:20-14:50
Recent update of endoscopic ultrasound in pancreatobiliary and liver disease

  • Diagnostic and therapeutic applications of endoscopic ultrasound in pancreatic disease Ichiro Yasuda
    University of Toyama, Japan
    CV ã
  • Diagnostic applications of endoscopic ultrasound in biliary disease Jae Hee Cho
    Yonsei University, Korea
    CV ã
  • Therapeutic applications of endoscopic ultrasound in biliary disease Tae Jun Song
    University of Ulsan, Korea
    CV ã
  • Emerging role of endoscopic ultrasound in hepatology Nonthalee Pausawasdi
    Mahidol University, Thailand
    CV ã

[The 8th Joint Session between KDDW-TDDW-JDDW] Liver : Nov. 15 (Fri), 13:20-15:35
New paradigms in the diagnosis and treatment of steatotic liver diseases

  • From NAFLD to MASLD : Asian perspectives for the change Byoung Kuk Jang
    Keimyung University, Korea
    CV ã
  • Impact of MASLD on long-term outcomes in chronic hepatitis B patients Tai-Chung Tseng
    National Taiwan University Hospital, Taiwan
    CV ã
  • Cutting-edge: noninvasive tests for the management of MASLD Masato Yoneda
    Yokohama City University, Japan
    CV ã
  • General Discussion Jung Il Lee
    Yonsei University, Korea
    ã
  • Liver disease modeling using induced pluripotent stem-cell: how to mimic mature hepatocyte Eun Sun Jang
    Seoul National University, Korea
    CV ã
  • Safety after finite nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients Yen-Chun Liu
    Linkou Chang Gung Memorial Hospital, Taiwan
    CV ã
  • Natural history of MASLD and risk of complications Nobuharu Tamaki
    Musashino Red Cross Hospital, Japan
    CV ã

[The 8th Joint Session between KDDW-TDDW-JDDW] Lower GI : Nov. 15 (Fri), 13:20-15:35
The latest in multidisciplinary approaches to colorectal neuroendocrine tumors

  • Utilizing high-frequency endoscopic ultrasound for decision-making in the management of colorectal subepithelial lesions, including rectal neuroendocrine tumors Dong-Hoon Yang
    University of Ulsan, Korea
    CV ã
  • Evaluating resection strategies for colorectal neuroendocrine tumors: can endoscopic intervention play a role? Wey-Ran Lin
    Linkou Chang Gung Memorial Hospital, Taiwan
    CV ã
  • Short-term outcomes of endoscopic resection for colorectal neuroendocrine tumors; results from the C-NET study Kenichiro Imai
    Shizuoka Cancer Center, Japan
    CV ã
  • General Discussion Hyun Gun Kim
    Soonchunhyang University, Korea
    ã
  • Optimizing outcomes in rectal NETs management: comparative analysis of endoscopic technique and surveillance protocol Seung Min Hong
    Pusan National University, Korea
    ã
  • Resection of rectal neuroendocrine tumor, which method is better? Yen-Po Wang
    Taipei Veterans General Hospital, Taiwan
    CV ã
  • Efficacy of endoscopic submucosal resection with a ligation device for small rectal neuroendocrine tumor: a multicenter open-label randomized control trial Kazunori Takada
    Shizuoka Cancer Center, Japan
    CV ã

PG Course 03 : Nov. 15 (Fri), 13:20-14:50
Holistic care for gastrointestinal cancer patients

  • Risk factors and management of serious complications: obstruction, bleeding, perforation Byung Wook Jung
    Hanyang University, Korea
    CV ã
  • Cachexia and nutritional support Hee Seok Moon
    Chungnam National University, Korea
    CV ã
  • Psychosocial support and hospice Seockhoon Chung
    University of Ulsan, Korea
    CV ã
  • Navigating long-term survivorship: addressing the challenges of young patients Dong Jun Oh
    Dongguk University, Korea
    CV ã

Combined Symposium 08 (KSG+AGA) : Nov. 15 (Fri), 15:10-16:40
Cutting-edge and current trends in upper & lower GI diseases

  • Emergency endoscopy system and technical issues for upper GI bleeding in Korea Ji Yong Ahn
    University of Ulsan, Korea
    CV ã
  • Emergency endoscopy system and technical issues for upper GI bleeding in the USA Byron Cryer
    Baylor University Medical Center, USA
    CV ã
  • Anti-TNF therapies for IBD: from intravenous to subcutaneous administration Sung Noh Hong
    Sungkyunkwan University, Korea
    CV ã
  • Anti-interleukin therapies for IBD: evolving data and clinical experiences Fernando Velayos
    Kaiser Permanente Northern California, USA
    ã

Symposium 20 : Nov. 15 (Fri), 15:10-16:40
Gastric cancer: prevention, detection, and treatment

  • Paradigm shift in gastric cancer prevention: current evidence Sun-Young Lee
    Konkuk University, Korea
    CV ã
  • Role of screening and early detection Young-Il Kim
    National Cancer Center, Korea
    ã
  • Endoscopic treatment of early gastric cancer: how far can we go? Moon Kyung Joo
    Korea University, Korea
    CV ã
  • Pattern of metachronous recurrence after endoscopic resection of gastric cancer and dysplasia Dae Young Cheung
    The Catholic University of Korea, Korea
    CV ã

Symposium 13 : Nov. 15 (Fri), 8:30-10:00
Microbiome in GI diseases

  • Role of microbiota-derived metabolites in alcoholic liver diseases Ji-Won Park
    Hallym University, Korea
    CV ã
  • What is the best strategy for modulating microbiome in FGIDs ? Cheol Min Shin
    Seoul National University, Korea
    CV ã
  • Development of microbial therapeutics in IBD: hurdles and potential solutions Gwang Pyo Ko
    Seoul National University, Korea
    ã
  • Dysbiotic change in gastric microbiome in gastric carcinogenesis: beyond helicobacter pylori Jae Yong Park
    Chung-Ang University, Korea
    CV ã

Symposium 14 : Nov. 15 (Fri), 8:30-10:00
Sarcopenia in liver diseases: from molecular insights to clinical strategies

  • Comprehensive assessment of sarcopenia and frailty: how and by which tools? Bo Kyung Koo
    Seoul National University, Korea
    CV ã
  • Sarcopenia in cirrhosis: from pathogenesis to prognosis Sae Kyung Joo
    Seoul National University, Korea
    CV ã
  • Sarcopenia in MASLD : an altered liver-muscle crosstalk Sung Hwan Yoo
    Yonsei University, Korea
    CV ã
  • Multidisciplinary therapeutic strategies for sarcopenia Do Seon Song
    The Catholic University of Korea, Korea
    CV ã

Symposium 15 : Nov. 15 (Fri), 8:30-10:00
Various methods to enhance the quality of colon cancer screening

  • Colorectal cancer screening tests: options, strategies, and perspectives Yu-min Lin
    Shin Kong Wu Ho-Su Memorial Hospital, Taiwan
    CV ã
  • New bowel preparation agents for colonoscopy: benefits and drawbacks Dong Hoon Baek
    Pusan National University, Korea
    CV ã
  • The role of withdrawal techniques and technological innovations in boosting adenoma detection during colonoscopy Katsuro Ichimasa
    Showa University Northern Yokohama Hospital, Japan
    CV ã
  • Optimizing post-polypectomy surveillance: finding the right follow-up time Su Young Kim
    Yonsei University Wonju, Korea
    CV ã

Symposium 16 : Nov. 15 (Fri), 8:30-10:00
Interesting topics in management of constipation

  • Constipation related to systemic disease Seon-Young Park
    Chonnam National University, Korea
    CV ã
  • Opioid-induced constipation Satish SC Rao
    Augusta University, USA
    CV ã
  • Constipation in elderly patients Tae Hee Lee
    Soonchunhyang University, Korea
    CV ã
  • Nonmedical therapies for chronic constipation & vibrating capsule Satish SC Rao
    Augusta University, USA
    CV ã

Combined Symposium 03 (KSGC+KCHUGR) : Nov. 15 (Fri), 8:30-10:00
Being a part of a multidisciplinary team, the role of a gastroenterologist and medical oncologist in upper gastrointestinal cancer

  • Endoscopic resection of early esophagogastric cancer Sujin Kim
    Pusan National University, Korea
    CV ã
  • Endoscopic management of malignant obstruction and bleeding in upper gastrointestinal cancer Da Hyun Jung
    Yonsei University, Korea
    CV ã
  • Neoadjuvant and adjuvant therapy of upper gastrointestinal cancer Sung Eun Kim
    Kosin University, Korea
    CV ã
  • Endoscopic management of postoperative complications in upper gastrointestinal cancer Ji Yong Ahn
    University of Ulsan, Korea
    CV ã

PG Course 01 : Nov. 15 (Fri), 8:30-10:00
Recent update on management of acute pancreatitis

  • Risk stratification and prognostication in acute pancreatitis Jung Hyun Jo
    Yonsei University, Korea
    ã
  • Update on the strategy for intravenous fluid treatment in acute pancreatitis Jae Min Lee
    Korea University, Korea
    CV ã
  • Nutritional support strategy in acute pancreatitis Eui Joo Kim
    Gachon University, Korea
    CV ã
  • Management of delayed complication in acute pancreatitis Young Hoon Choi
    Sungkyunkwan University, Korea
    CV ã
Supported by Member Societies
Associated Society
Supported by
Endorsed By
Diamond
Platinum
  • Daewoong
  • Innovate new and next
Gold
  • 제일팜
  • 올림푸스
Silver
Bronze
  • 한국오츠카
  • 일동제약
  • 유한양행
Sapphire
  • 삼성바이오에피스
  • 에브비
  • 셀트리온
  • 한미약품
  • 셀벡스

Go to Top

케이디디더블유 운영협의체

Business License No.: 609-82-84671

President: Jong-Jae Park

E-mail : gie@kams.or.kr

Address : Room 817 LG Palace, 156, Yanghwa-ro, Mapo-gu, Seoul 04050, Korea
KDDW 2024 Secretariat
Contact (Scientific Program & Abstract)
kddw2024info@medioffice.or.kr / Tel. +82-10-2334-8265
(Registration & Sponsor)
Email.kddw2024@medioffice.or.kr / Tel. +82-2-459-8266